Document is current

Any future updates will be listed below

Infographic: Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, Phase 3 trial

Crossref DOI link: https://doi.org/10.1038/s41433-026-04564-4

Published Online: 2026-05-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark